Logo

Evofem Biosciences' Phexxi (lactic acid- citric acid- and potassium bitartrate) Vaginal Gel Receives the US FDA's Approval for the Prevention of Pregnancy

Share this

Evofem Biosciences' Phexxi (lactic acid- citric acid- and potassium bitartrate) Vaginal Gel Receives the US FDA's Approval for the Prevention of Pregnancy

Shots:

  • Phexxi is a novel non-hormonal- on-demand- vaginal pH regulator contraceptive designed to maintain vaginal pH within normal range of 3.5 to 4.5 (an acidic environment) which is not suitable for a sperm
  • In Sep 2010- the company plans for the launch of Phexxi Concierge Experience a patient and healthcare provider telemedicine support system which offers services to physicians and on-demand educational support- and speed and simplify women's access to Phexxi  
  • The offering will help women to have prescription determine their insurance coverage and/or out-of-pocket costs- receive counseling support and refill reminders for the drug

Click here to read full press release/ article | Ref: Evofem Biosciences | Image: Behance


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions